Furthermore, integrating gene expression data with therapeutic response profiles (e.g., to IL-17 or TNF inhibitors) could facilitate the identification of novel predictive biomarkers and advance personalized treatment strategies in psoriasis. The gene discussed is IL17A; the disease is psoriasis.